Ftse Mib
34.016,64
1,15%
DAX
18.165,90
0,96%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.184,02
0,29%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ XORTX Therapeutics Inc (XRTX) XORTX Therapeutics Inc (XRTX) Notizie

XRTX

XORTX Therapeutics (XRTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XRTX
DataOraFonteTitoloSimboloCompagnia
30/04/202419:54GlobeNewswire Inc.XORTX Reprices Warrants Issued in Connection with Previous Private PlacementsNASDAQ:XRTXXORTX Therapeutics Inc
22/04/202413:00GlobeNewswire Inc.XORTX Announces Publication of Key Research in ADPKDNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202413:30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:XRTXXORTX Therapeutics Inc
08/04/202413:00GlobeNewswire Inc.XORTX Announces Participation in Spring 2024 Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
27/03/202410:00GlobeNewswire Inc.XORTX Announces New Clinical Advisory Board MemberNASDAQ:XRTXXORTX Therapeutics Inc
19/03/202410:00GlobeNewswire Inc.XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialNASDAQ:XRTXXORTX Therapeutics Inc
04/03/202413:00GlobeNewswire Inc.XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/02/202413:00GlobeNewswire Inc.XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
02/02/202402:46GlobeNewswire Inc.XORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
15/01/202413:00GlobeNewswire Inc.XORTX Announces $2 Million Public OfferingNASDAQ:XRTXXORTX Therapeutics Inc
03/01/202413:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
03/01/202413:00GlobeNewswire Inc.XORTX Submits a New Patent for the Treatment of Chronic Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
30/11/202313:30GlobeNewswire Inc.XORTX Announces US ATM OfferingNASDAQ:XRTXXORTX Therapeutics Inc
30/11/202303:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
29/11/202313:00GlobeNewswire Inc.XORTX Meets Nasdaq Continued Listing RequirementsNASDAQ:XRTXXORTX Therapeutics Inc
10/11/202313:00GlobeNewswire Inc.XORTX Clarifies Timing for Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
08/11/202323:00GlobeNewswire Inc.XORTX Announces Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
02/11/202312:00GlobeNewswire Inc.XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
27/10/202323:30GlobeNewswire Inc.XORTX Announces Results of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
25/10/202323:00GlobeNewswire Inc.XORTX Announces Date for Rescheduled Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
25/10/202313:00GlobeNewswire Inc.XORTX Announces Rescheduling of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
12/10/202313:00GlobeNewswire Inc.XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation ResolutionNASDAQ:XRTXXORTX Therapeutics Inc
04/10/202313:00GlobeNewswire Inc.XORTX Calls Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
28/09/202313:00GlobeNewswire Inc.XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
11/09/202313:00GlobeNewswire Inc.XORTX Announces Participation at Upcoming Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
07/09/202313:00GlobeNewswire Inc.XORTX Joins the Kidney Foundation and Kidney MarchNASDAQ:XRTXXORTX Therapeutics Inc
29/08/202313:00GlobeNewswire Inc.XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
25/08/202312:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
08/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XRTXXORTX Therapeutics Inc
04/08/202323:00GlobeNewswire Inc.XORTX Appoints Chief Financial OfficerNASDAQ:XRTXXORTX Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XRTX

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
AMP
Amplifon
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
TIT
Telecom Italia
BIT
TRN
Terna Trasmissione Elett...
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network